ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC57.3

C57.3

Billable

Malignant neoplasm of parametrium

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C57.3 is a billable code used to indicate a diagnosis of malignant neoplasm of parametrium.

Key Diagnostic Point:

Malignant neoplasm of the parametrium refers to cancerous growths that occur in the connective tissue surrounding the uterus. This condition is often associated with other gynecologic malignancies, particularly cervical and endometrial cancers. The parametrium is critical in supporting the uterus and is involved in the spread of gynecologic cancers. Symptoms may include abnormal vaginal bleeding, pelvic pain, and urinary symptoms. Diagnosis typically involves imaging studies, biopsy, and staging to determine the extent of the disease. Staging is crucial as it guides treatment options, which may include surgery, radiation, and chemotherapy. The CA-125 blood test, while not specific to parametrium neoplasms, can be elevated in cases of ovarian and other gynecologic cancers, providing additional diagnostic information. Treatment often involves surgical approaches such as hysterectomy, which may include removal of surrounding tissues, depending on the extent of the malignancy. Accurate coding is essential for appropriate treatment planning and reimbursement.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between primary and metastatic neoplasms
  • Staging requirements for accurate coding
  • Documentation of associated symptoms and findings
  • Need for comprehensive surgical documentation

Audit Risk Factors

  • Inadequate documentation of staging
  • Failure to document associated symptoms
  • Misclassification of the primary site of malignancy
  • Lack of clarity in surgical documentation

Specialty Focus

Medical Specialties

Gynecologic Oncology

Documentation Requirements

Detailed surgical reports, pathology results, imaging studies, and staging information.

Common Clinical Scenarios

Patients presenting with abnormal bleeding, pelvic masses, or pain; follow-up after treatment for gynecologic cancers.

Billing Considerations

Ensure all relevant findings are documented, including tumor size, grade, and lymph node involvement.

Radiology

Documentation Requirements

Imaging reports that detail the extent of the tumor and any metastasis.

Common Clinical Scenarios

Imaging for staging, follow-up imaging post-treatment, and imaging for symptom evaluation.

Billing Considerations

Clear documentation of imaging findings is crucial for accurate coding and staging.

Coding Guidelines

Inclusion Criteria

Use C57.3 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the primary site, staging, and any associated conditions
  • Include details on the extent of the disease and treatment plans

Exclusion Criteria

Do NOT use C57.3 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

58150CPT Code

Total abdominal hysterectomy

Clinical Scenario

Performed for malignant neoplasm of the parametrium.

Documentation Requirements

Operative report detailing the procedure, findings, and any complications.

Specialty Considerations

Ensure that the surgical approach and extent of resection are clearly documented.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of gynecologic malignancies, including C57.3, which enhances the ability to track and manage these conditions more effectively. It has improved the granularity of data for research and treatment outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of gynecologic malignancies, including C57.3, which enhances the ability to track and manage these conditions more effectively. It has improved the granularity of data for research and treatment outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of gynecologic malignancies, including C57.3, which enhances the ability to track and manage these conditions more effectively. It has improved the granularity of data for research and treatment outcomes.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the significance of staging in coding C57.3?

Staging is crucial as it determines the extent of the disease and influences treatment options. Accurate staging must be documented to ensure appropriate coding and reimbursement.